306 related articles for article (PubMed ID: 34384425)
1. Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis.
Hirama T; Tomiyama F; Notsuda H; Watanabe T; Watanabe Y; Oishi H; Okada Y
BMC Pulm Med; 2021 Aug; 21(1):261. PubMed ID: 34384425
[TBL] [Abstract][Full Text] [Related]
2. Lung transplantation for non-cystic fibrosis bronchiectasis.
Rademacher J; Ringshausen FC; Suhling H; Fuge J; Marsch G; Warnecke G; Haverich A; Welte T; Gottlieb J
Respir Med; 2016 Jun; 115():60-5. PubMed ID: 27215505
[TBL] [Abstract][Full Text] [Related]
3. Allograft colonization and infections with pseudomonas in cystic fibrosis lung transplant recipients.
Nunley DR; Grgurich W; Iacono AT; Yousem S; Ohori NP; Keenan RJ; Dauber JH
Chest; 1998 May; 113(5):1235-43. PubMed ID: 9596300
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV
Ramos KJ; Quon BS; Heltshe SL; Mayer-Hamblett N; Lease ED; Aitken ML; Weiss NS; Goss CH
Chest; 2017 Jun; 151(6):1320-1328. PubMed ID: 28115168
[TBL] [Abstract][Full Text] [Related]
5. Survival in Patients with Advanced Non-cystic Fibrosis Bronchiectasis Versus Cystic Fibrosis on the Waitlist for Lung Transplantation.
Hayes D; Kopp BT; Tobias JD; Woodley FW; Mansour HM; Tumin D; Kirkby SE
Lung; 2015 Dec; 193(6):933-8. PubMed ID: 26429393
[TBL] [Abstract][Full Text] [Related]
6. Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients.
Vital D; Hofer M; Benden C; Holzmann D; Boehler A
Respiration; 2013; 86(1):25-31. PubMed ID: 22922656
[TBL] [Abstract][Full Text] [Related]
7. Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation.
Pritchard J; Thakrar MV; Somayaji R; Surette MG; Rabin HR; Helmersen D; Lien D; Purighalla S; Waddell B; Parkins MD
J Cyst Fibros; 2016 May; 15(3):392-9. PubMed ID: 26657575
[TBL] [Abstract][Full Text] [Related]
8. Lung transplantation for cystic fibrosis: differential characteristics and outcomes between children and adults.
Moreno P; Alvarez A; Carrasco G; Redel J; Guaman HD; Baamonde C; Algar FJ; Cerezo F; Salvatierra A
Eur J Cardiothorac Surg; 2016 May; 49(5):1334-43. PubMed ID: 26530270
[TBL] [Abstract][Full Text] [Related]
9. Effect of infection with transmissible strains of Pseudomonas aeruginosa on lung transplantation outcomes in patients with cystic fibrosis.
Srour N; Chaparro C; Vandemheen K; Singer LG; Keshavjee S; Aaron SD
J Heart Lung Transplant; 2015 Apr; 34(4):588-93. PubMed ID: 25455752
[TBL] [Abstract][Full Text] [Related]
10. Cystic Fibrosis Lung Transplant Recipients Have Suppressed Airway Interferon Responses during
Dugger DT; Fung M; Zlock L; Caldera S; Sharp L; Hays SR; Singer JP; Leard LE; Golden JA; Shah RJ; Kukreja J; Gordon E; Finkbeiner W; Kleinhenz ME; Langelier C; Greenland JR
Cell Rep Med; 2020 Jul; 1(4):. PubMed ID: 32754722
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis.
Snell GI; de Hoyos A; Krajden M; Winton T; Maurer JR
Chest; 1993 Feb; 103(2):466-71. PubMed ID: 7679347
[TBL] [Abstract][Full Text] [Related]
12. Chronic infection with Pseudomonas aeruginosa in cystic fibrosis: a risk factor for nasal polyposis after lung transplantation.
Vital D; Holzmann D; Boehler A; Hofer M
Transplantation; 2013 Jun; 95(12):1548-53. PubMed ID: 23624545
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa antibody response in cystic fibrosis decreases rapidly following lung transplantation.
Schwensen HF; Moser C; Perch M; Pressler T; Høiby N
J Cyst Fibros; 2020 Jul; 19(4):587-594. PubMed ID: 32044245
[TBL] [Abstract][Full Text] [Related]
14. Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients.
Luo RG; Miao XY; Luo LL; Mao B; Yu FY; Xu JF
Clin Microbiol Infect; 2019 May; 25(5):601-606. PubMed ID: 30036669
[TBL] [Abstract][Full Text] [Related]
15. Transplant center volume and outcomes in lung transplantation for cystic fibrosis.
Hayes D; Sweet SC; Benden C; Kopp BT; Goldfarb SB; Visner GA; Mallory GB; Tobias JD; Tumin D
Transpl Int; 2017 Apr; 30(4):371-377. PubMed ID: 28012223
[TBL] [Abstract][Full Text] [Related]
16. Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodies.
Divithotawela C; Pham A; Bell PT; Ledger EL; Tan M; Yerkovich S; Grant M; Hopkins PM; Wells TJ; Chambers DC
J Heart Lung Transplant; 2021 Sep; 40(9):951-959. PubMed ID: 34226118
[TBL] [Abstract][Full Text] [Related]
17. Impact of gram negative bacteria airway recolonization on the occurrence of chronic lung allograft dysfunction after lung transplantation in a population of cystic fibrosis patients.
Orfanos S; Gomez C; Baron S; Akkisetty R; Dufeu N; Coltey B; Thomas PA; Rolain JM; Reynaud-Gaubert M
BMC Microbiol; 2018 Aug; 18(1):88. PubMed ID: 30126365
[TBL] [Abstract][Full Text] [Related]
18. Lung Transplantation for Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis: A Single-Center Experience.
Rusanov V; Fridman V; Wille K; Kramer MR
Transplant Proc; 2019; 51(6):2029-2034. PubMed ID: 31303417
[TBL] [Abstract][Full Text] [Related]
19. Impact of extended sinus surgery on allograft infection, allograft function and overall survival in cystic fibrosis lung transplant recipients.
Meier M; Schuurmans MM; Vital D; Inci I; Holzman D; Soyka MB
Eur Arch Otorhinolaryngol; 2023 Oct; 280(10):4501-4507. PubMed ID: 37249595
[TBL] [Abstract][Full Text] [Related]
20. [Lung transplant therapy for suppurative diseases].
de Pablo A; López S; Ussetti P; Carreño MC; Laporta R; López García-Gallo C; Ferreiro MJ
Arch Bronconeumol; 2005 May; 41(5):255-9. PubMed ID: 15919006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
